Immutep Limited American Depositary Shares

Go to Immutep Limited American Depositary Shares Website

$1.78

0.00 (0.00%)
Live
Previous Close

$1.78

Day Range

$0 - $0

Previous Day Range

$1.7 - $1.78

Market Cap

$253.3 million USD

Day Vol.

0

Previous Day Vol.

123677

Currency

USD

Primary Exchange

Nasdaq

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Immutep, a late-stage immunotherapy company, announces its management will present and participate in one-on-one meetings at upcoming investor conferences in Las Vegas, New York, and New York.

Related tickers: IMMP.

Read Full Article

The LAG-3 next-generation therapies market is expected to grow significantly in the coming years due to the potential entry of major LAG-3 candidates, increase in incident cases of various solid tumors, and improvement in patient outcomes.

Related tickers: MRK, ADAP, REGN, IMMP.

Read Full Article
Trending Tickers

Please sign in to view